cilostazol has been researched along with alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumura, A; Nakamura, K; Suzuki, K; Takigawa, T; Tsurushima, H; Tsuruta, W | 1 |
1 other study(ies) available for cilostazol and alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc
| Article | Year |
|---|---|
Cilostazol suppression of arterial intimal hyperplasia is associated with decreased expression of sialyl Lewis X homing receptors on mononuclear cells and E-selectin in endothelial cells.
Topics: Angioplasty, Balloon; Animals; Anti-Inflammatory Agents; Carotid Arteries; Carotid Artery Injuries; Cell Proliferation; Cells, Cultured; Cilostazol; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; E-Selectin; Endothelial Cells; Fluorescent Antibody Technique; Human Umbilical Vein Endothelial Cells; Humans; Hyperplasia; Leukocytes, Mononuclear; Male; Oligosaccharides; Phosphodiesterase 3 Inhibitors; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Sialyl Lewis X Antigen; T-Lymphocytes; Tetrazoles; Time Factors; Tunica Intima | 2012 |